vs
Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $173.1M, roughly 1.2× PATHWARD FINANCIAL, INC.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 20.3%, a 37.1% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $104.1M).
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
CASH vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $173.1M | $207.8M |
| Net Profit | $35.2M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 24.6% | 52.2% |
| Net Margin | 20.3% | 57.4% |
| Revenue YoY | -0.2% | — |
| Net Profit YoY | 11.9% | 330.1% |
| EPS (diluted) | $1.57 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $173.1M | — | ||
| Q3 25 | $186.7M | $207.8M | ||
| Q2 25 | $195.8M | — | ||
| Q1 25 | $274.8M | — | ||
| Q4 24 | $182.6M | — | ||
| Q3 24 | $179.5M | $0 | ||
| Q2 24 | $188.6M | $0 | ||
| Q1 24 | $257.6M | $0 |
| Q4 25 | $35.2M | — | ||
| Q3 25 | $38.8M | $119.2M | ||
| Q2 25 | $42.1M | — | ||
| Q1 25 | $75.0M | — | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $33.5M | $-51.8M | ||
| Q2 24 | $44.9M | $-52.8M | ||
| Q1 24 | $69.9M | $-39.6M |
| Q4 25 | 24.6% | — | ||
| Q3 25 | 25.9% | 52.2% | ||
| Q2 25 | 24.1% | — | ||
| Q1 25 | 33.2% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.9% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 33.8% | — |
| Q4 25 | 20.3% | — | ||
| Q3 25 | 20.8% | 57.4% | ||
| Q2 25 | 21.5% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 16.4% | — | ||
| Q3 24 | 18.7% | — | ||
| Q2 24 | 23.8% | — | ||
| Q1 24 | 27.1% | — |
| Q4 25 | $1.57 | — | ||
| Q3 25 | $1.69 | $1.33 | ||
| Q2 25 | $1.81 | — | ||
| Q1 25 | $3.14 | — | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $1.34 | $-0.60 | ||
| Q2 24 | $1.78 | $-0.68 | ||
| Q1 24 | $2.74 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $331.2M | $786.9M |
| Total DebtLower is stronger | $33.5M | — |
| Stockholders' EquityBook value | $854.5M | $1.1B |
| Total Assets | $7.6B | $1.2B |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $331.2M | — | ||
| Q3 25 | $120.6M | $786.9M | ||
| Q2 25 | $258.3M | — | ||
| Q1 25 | $254.2M | — | ||
| Q4 24 | $597.4M | — | ||
| Q3 24 | $158.3M | $920.0M | ||
| Q2 24 | $298.9M | $701.7M | ||
| Q1 24 | $347.9M | $698.8M |
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.5M | — | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $33.4M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $33.4M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $33.4M | — |
| Q4 25 | $854.5M | — | ||
| Q3 25 | $858.0M | $1.1B | ||
| Q2 25 | $819.0M | — | ||
| Q1 25 | $814.7M | — | ||
| Q4 24 | $758.3M | — | ||
| Q3 24 | $822.5M | $1.2B | ||
| Q2 24 | $748.4M | $931.7M | ||
| Q1 24 | $719.5M | $935.3M |
| Q4 25 | $7.6B | — | ||
| Q3 25 | $7.2B | $1.2B | ||
| Q2 25 | $7.2B | — | ||
| Q1 25 | $7.0B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.5B | $1.2B | ||
| Q2 24 | $7.5B | $973.7M | ||
| Q1 24 | $7.4B | $961.5M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.05× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.3M | $142.2M |
| Free Cash FlowOCF − Capex | $104.1M | $142.2M |
| FCF MarginFCF / Revenue | 60.1% | 68.4% |
| Capex IntensityCapex / Revenue | 2.4% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.08× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $616.8M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.3M | — | ||
| Q3 25 | $303.7M | $142.2M | ||
| Q2 25 | $30.4M | — | ||
| Q1 25 | $188.3M | — | ||
| Q4 24 | $-71.7M | — | ||
| Q3 24 | $143.1M | $-49.2M | ||
| Q2 24 | $113.2M | $-32.9M | ||
| Q1 24 | $203.0M | $-43.8M |
| Q4 25 | $104.1M | — | ||
| Q3 25 | $300.3M | $142.2M | ||
| Q2 25 | $27.7M | — | ||
| Q1 25 | $184.7M | — | ||
| Q4 24 | $-73.8M | — | ||
| Q3 24 | $138.8M | $-49.7M | ||
| Q2 24 | $111.0M | $-33.9M | ||
| Q1 24 | $201.3M | $-45.1M |
| Q4 25 | 60.1% | — | ||
| Q3 25 | 160.9% | 68.4% | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | -40.4% | — | ||
| Q3 24 | 77.3% | — | ||
| Q2 24 | 58.8% | — | ||
| Q1 24 | 78.1% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 3.08× | — | ||
| Q3 25 | 7.83× | 1.19× | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | -2.39× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 2.52× | — | ||
| Q1 24 | 2.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
IDYA
Segment breakdown not available.
